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  Cardiovascular diseases are the leading causes of worldwide mortality. Although, is the 
core of a considerable number of studies, myocardial infarction remains one of the major fatal 
cardiovascular disorders resulting from obstruction of coronary arteries and cardiomyocyte 
destruction. 
Diseases of the cardiovascular system affect the heart and blood vessels (arteries, veins and 
capillaries). With aging, physiological and morphological changes can alter the functions of the 
cardiovascular system and the risk of cardiovascular disease increases dramatically. The majority 
of diseases and deaths due to cardiovascular disease have as their primary triggering factor 
atherosclerosis. This process begins with the thickening and stiffening of the arterial wall due to 
cholesterol deposition in the vessels walls, thereby forming atheromatous plaques, which results 
in obstruction of blood flow. Atherosclerosis affects all the arteries in the body. The onset of 
atherosclerosis in the coronary arteries is an early one, this disease being called coronary disease, 
which can cause acute myocardial infarction (AMI) at the advanced stage of development. AMI is 
the result of obstructing blood flow, thereby reducing the oxygen supply to the myocardium, 
ultimately resulting in tissue damage. The affected area becomes hypoxic, triggering inflammatory 
processes and subsequently regeneration. Heart remodeling is final by scarring the damaged tissue. 
Recent advances in stem cell research for tissue regeneration highlight the potential use of 
pluripotent/precursor adult stem cells for the reconstruction or regeneration of different tissues 
without the inclusion of ethical issues (Nesselmann et al., 2008, Karantalis & Hare 2015, Singh et 
al., 2016a). In this context, multipotent mesenchymal stromal cells (MSC) that are capable of 
transforming into different cell types have gained attention to serve as a therapeutic tool for 
permanent repair/regeneration of damaged cardiac tissue. MSC are of mesodermal origin and can 
be differentiated into different types of cells (endothelial cells, osteoblasts, chondrocytes, 
adipocytes, myocytes) when exposed to specific growth factors, signaling molecules and 
transcription factors (Karantalis & Hare 2015). 
More importantly, they can be grown and prepared for in vitro delivery (Karantalis & Hare 
2015). MSC can be isolated from multiple sources (fat, placenta, intestine, lung, liver, amniotic 
fluid, dental pulp, periodontal pulp, heart). Together, multiple tissue sources and the pluripotent 
nature of MSC in sync with ease of in vitro expansion make them a curative therapeutic tool for 
treating cardiac lesions. 
Over the past decade, several clinical trials have been observed in both animals and 
humans, assessing the therapeutic potential of MSC in repairing cardiac lesions and 
functions (Nesselmannet al., 2008, Singh et al., 2016b). Although many studies (not all) have 
been established in which MSC therapy can lead to a potential improvement in neovascularization, 
scarring and functional recovery, a major barrier to MSCs therapy is the low retention of 
transplanted cells, ie 0.44% of transplanted MSC are found in the myocardium after 4 
days (Toma et al., 2002; Müller-Ehmsen et al., 2006). This has led to a demand for further 
optimization of MSC therapy by identifying molecules that could be used to receive/treat MSCs 
or recipients to increase MSC’s ability to regenerate the ischemic area (Novotny et al.,2008). Since 
it has been shown that androgens stimulate growth influences cell activity cardiovascular (Yeap et 
al. 2003; Ikeda et al. 2005), promotes the growth and angiogenesis in endothelial progenitor cells 
(EPC) and mesenchymal stromal cells (Cai et al. 2016), we assume that androgen can also 
facilitate the adhesion and integration into the ischemic tissue of both MSC and EPC. 
Endothelial cells (EC) are needed for tissue repair and wound healing by building a new 
blood vessel network. Interestingly, in addition to residual EC, circulating EPCs derived from bone 
marrow and spleen were found to be actively involved in vascular repair. Therefore, our main 
focus was also studying the effects of androgen on the EPC function. The relationship between 
testosterone deficiency and the reduced number of circulating EPCs is a hallmark of cardiovascular 
disorders, as demonstrated in hypogonadal patients (Foresta et al., 2006, Calogero et al., 2017). 
There are plenty of evidences suggesting a central role of androgen in male cardiovascular 
health. Despite numerous studies to decipher the precise roles of testosterone (T) in cardiovascular 
disease (CVD), no agreement has been reached on the protective or harmful effects of T on the 
cardiovascular system (CVS). It is therefore essential to clarify how T affects CVS in order to 
identify the potential risks and benefits of testosterone replacement therapy (TST), increasingly 
used by older men. 
 We assume that androgens also modulate vascular remodeling processes associated with 
CVD. In the foreground, there is the ability of MSC and EPC to migrate, the pro-angiogenic 
responsiveness of both cell types and, last but not least, the chemokines activated in response to 
androgen pre-treatment. All of these processes are aimed at improving cardiovascular ischemia 
regeneration capacity. 
To answer these questions, we used dihydrotestosterone (DHT), a T-metabolite that mimics 
the effects of T and cannot be converted to estradiol. Therefore, DHT use can certify that the 
observed effects are only androgenic and are not compromised by conversion to estradiol. 
Knowing all of the above, we have delivered the potent basis of this study, namely: it is 
possible to enhance the capacity of MSC and EPC to adhere, integrate and proliferate by pre-
stimulation with androgenic hormones in such a way that chances of ischemic regeneration 
cardiovascular to be improved? 
In the first part of the doctoral dissertation are briefly described the theoretical aspects 
related to the structure and actions of androgenic hormones, characteristics and properties of 
mesenchymal stromal cells and progenitor endothelial cells, up-to-date aspects of androgen 
hormones and stromal/progenitor cells in the treatment of cardiovascular diseases. The second 
part of the thesis, which includes the original contributions of this doctoral thesis, is divided into 
two major studies. 
  The first study covered "Studies on the effect of dihydrotestosterone on the 
proliferation, migration and integration of MSC in murine ventricular slices" and is 
characterized by two general objectives: 
 investigating the effects of DHT on the proliferation, migration and adhesion of MSC to 
murine myocardium; 
 and assessing the role of AR in the modulating effects of DHT on MSC functions. 
  
The second study refers to "Research on the effect of dihydrotestosterone on proliferation, 
migration and integration of human progenitor endothelial cells in murine ventricular 
sections" and is divided into two parts: 
 determining the molecules that can mediate DHT-induced effects on EPC migration/ 
adhesion functions in the murine myocardium; 
 evaluating the interaction between AR and EPC activity after pre-treatment with DHT. 
 
To meet all the objectives of this PhD thesis, we have used various techniques of biochemistry, 
molecular biology and cell cultures that have been described in detail in the 
section "Materials and Methods" characteristic of each chapter. For better reproducibility of the 
results obtained, the protocol for obtaining the mouse heart sections was optimized together with 
the adhesion of the heart sections on the bottom culture wells. A patented method has been 
developed, that allowed us to measure in real-time the cells migration based on cellular impedance, 
using the xCELLigence device. Also, a method was optimized for quantifying human cells in the 
direct co-culture model between MSC or EPC and the murine heart slices using the qRT-PCR 
technique. 
  Increased life expectancy is also accompanied by increased demand for improved quality 
of life and prevention of aging diseases. Since testosterone deficiency was suggested to be 
associated with CVD, the number of men undergoing testosterone supplementation (TST) 
increased. However, some studies have reported adverse effects of TST and increased mortality 
due to CVD. Therefore, it is necessary to understand the role of T in cardiovascular health and if 
TST is beneficial. The role of EPC in cardiovascular regeneration is well established and is 
currently being used in cardiovascular therapy. In hypogonadal men, it has been shown that lower 
levels of EPC are directly correlated with the predisposition of cardiovascular disease 
development. 
Consistent with these findings, the original results show that the hypothesis issued in the 
present study were correct as follows: 
 DHT increases the proliferation and ability of MSC to adhere to cardiac tissue; 
 In MSC, the proteins and genes expression of MMP-2, MMP-9 and EMMPRIN is 
modulated by DHT; 
 DHT increases migration and chemotaxis of MSC to cardiac tissue; 
 The secretion of angiogenin, VEGF and NO - key factors in the process of ischemic tissue 
regeneration is increased in DHT-stimulated MSC; 
 MSC cytoskeleton proteins involved in cell migration are activated following stimulation 
with DHT; 
 DHT induces increased proliferation, migration and EPC's ability to form capillary 
networks on Matrigel® substrate in an AR-dependent manner; 
 Proteolytic key molecules (EMMPRIN and MMP-9) are also upregulated by DHT 
treatment; 
 The secretion of angiogenin, VEGF and PLGF - key factors involved in the onset and 
development of regenerative processes by angiogenesis is increased in DHT-stimulated 
EPC; 
 By stimulating with DHT the EPC activates large protein groups that are involved in 
signaling the response to injury, wound healing, the metabolic process of the 
organonitrogen compound. 
 
The main results of the first part of this thesis build up the role of DHT in the growth, 
proliferation and migration of MSC and in promoting the integration of these cells in cardiac tissue 
in vitro. These effects are accompanied by an increase in AR expression and key molecules known 
to promote tissue remodeling and angiogenesis (EMMPRIN, MMP-2, MMP-9, VEGF, 
angiogenin, NO). These original data contained in the first study of this doctoral thesis were 
reflected in the article entitled: "Dihydrotestosterone induces pro-angiogenic factors and assists 
homing of MSC into the cardiac tissue ", has as authors: Popa MA * , Mihai MC * , Constantin A, 
Șuică V, Țucureanu C, Costache R, Antohe F, Dubey RK & Simionescu M (* equal contribution) 
and published in 2018 in the Journal of Molecular Endocrinology 60 1-15. (doi: 10.1530 / JME-
17-0185) (Impact factor 2017 IF= 3.29). 
The main data from the second part deciphers another role of DHT following EPC 
stimulation. We have shown that DHT regulates the EPC function of forming capillary tube -like 
structures by increasing the number of closed structures. We have shown that AR is involved in 
cell migration processes in the presence of DHT. Moreover, we have shown that DHT regulated 
the expression of proteins involved in cell migration, EMMPRIN and MMP-9, and the expression 
of pro-angiogenic proteins is increased due to the presence of DHT (VEGF, VEGFR-2, angiogenin 
and PlGF). We assume that DHT also activates the PI3-k/AKT signaling pathway through AR, a 
pathway that enhances EPC proliferation and cellular proliferation (Liu et al., 2014). Therefore, 
our research supports the concept of the protective effects of androgen on EPC function by 
stimulating the formation of new blood vessels and improving the endothelial integrity. This 
original data is part of an article to be published. 
The new data from our experiments indicates that in vitro DHT stimulation of MSC and EPC 
retains cell properties and significantly increases adhesion and cell proliferation. However, 
additional studies are needed to determine the mechanisms involved in the effect of DHT on the 
survival, mobilization and stimulation of MSC and EPC. Increasing the proliferation potential of 
MSC and EPC stimulated with DHT without affecting the potential for action could make these 
cells not only a simple candidate, but an excellent option for vascular regenerative medicine and 
ischemic illnesses in general. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perspectives 
The therapeutic use of mesenchymal stromal cells and progenitor endothelial cells in the 
treatment of cardiovascular lesions has not yet reached its potential due to the reduced efficiency 
of grafting in the damaged tissue but also to the deficient mechanisms of the host organism. In this 
paper we have demonstrated that pre-treatment of MSC and EPC with DHT improves cellular 
migration capacity in response to cardiac stimuli and also increases the pro-angiogenic profile of 
stimulated cells. 
A future project would be based on experiments to investigate the mechanisms and effects 
of DHT on co-culture between MSC and EPC co-cultivated in the presence of murine 
sections. Since the proteolytic activity of cells is stimulated by the presence of DHT, it is also 
noticeable how the set of pro-inflammatory cytokines in the onset of post-ischemic fibrosis is 
affected. 
             An intermediate step of the future project is the use of DHT-stimulated cells in tissue 
engineering as a support for ex vivo grafts. Knowing that cells behave differently in a two-
dimensional construct, analyzing the functions and molecules activated by three-dimensional 
cultivation can reveal new functions. The emphasis will be placed on the proteolytic activity of 
MMP and the synthesis of pro-angiogenic factors to which the set of vascular ischemia-specific 
immune modulators will be added. 
            Before proceeding to in vivo experiments, all of the data will be added as a variable in 
an in silico simulation model which will be based on artificial intelligence algorithms. These 
in silico algorithms will be structured in the form of databases and neural networks that will 
simulate possible ways of action by the molecules of interest based on probabilities. This analysis 
aims at streamlining in vivo studies and minimizing confirmatory experiments on animal subjects. 
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derived mesenchymal stem cells, "7th Annual Congress of the German Society for 
Stem Cell Research ", 28 to 30 October 2013, Leipzig, Germany; 
3. Ciprian Neagoe, Mirel Adrian Popa. " Numerical simulation of leukocyte adhesion to 
endovascular surfaces ". 1st International Conference on Emerging Technologies in 
Materials Engineering EmergeMAT and 4th International Workshop on Materials under 
Extreme Conditions SUPERMAT. 14-16 November 2018, Bucharest, Romania. 
  
ORAL COMMUNICATIONS AND POSTERS SUPPORTED TO NATIONAL 
SCIENTIFIC MANIFESTATIONS - MAIN AUTHOR AND CO-AUTHOR 
  
1. Maria Cristina Corotchi, Mirel Adrian Popa, Marilena Lupu. "Characterization of 
multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem 
cells isolated and expanded in xenobiotic-free conditions ", RAMSES Annual International 
Workshop, 13-16 September 2012, Nicolae Simionescu Institute of Cell Biology and 
Pathology, Bucharest, Romania.  
 
SPECIALIZATIONS AND COURSES PERFORMED 
 Congress "The first international society of regenerative medicine and surgery congress. 
New frontiers in regenerative medicine and surgery. Interdisciplinarity, Research and 
Clinical Applications ", Bucharest, Romania, May 15 - 16, 2015; 
 
 The International Congress of Regenerative Medicine. Regenerative medicine; research 
and clinical applications, Bucharest, Romania, 14-17 June 2017.       
   
NATIONAL PRIZES OBTAINED 
 Best Poster Award (1st place) - Mirel Adrian Popa*, Anca Remeș*, Maria Cristina 
Corotchi, Marilena Lupu (* equal contribution). "Gene and protein profiling of human 
Wharton's Jelly-derived stem / progenitor cells upon exposure       to Endothelial 
Differentiation Conditions ", The 4th International Congress and the 30th Annual Scientific 
Session of the Romanian Society for Cell Biology, 13-17 June 2012, Satu-Mare, Romania 
and Debrecen, Hungary; 
 
 Best Poster Award (1st place) - Maria Cristina Corotchi *, Anca Remeș *, Mirel Adrian 
Popa, Livia Sima, Marilena Lupu (* equal contribution). " Characterization of multipotent 
differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells isolated 
and expanded in xenobiotic-free Conditions " The 4th International Congress and the 30th 
Annual Scientific Session of Romanian Society for Cell Biology, 13-17 June 2012, Satu-
Mare, Romania and Debrecen, Hungary; a summary published in the Bulletin of the 
National Society of Cell Biology, no. 40, p. 151. 
 
 National patent No. 131463/2018 awarded by UEFISCDI (Executive Unit for Financing 
Higher Education, Research, Development and Innovation) 
 
 
 
SCHOLARSHIPS BETWEEN DOCTORAL DURATION AND FINANCING OF 
RESEARCH 
 
 The Romanian Academy through SCOSAR (2013-2016); 
 
 POSDRU / 159 / 1.5 / s / 133391 "Doctoral and post-doctoral programs of excellence for 
the   training of highly qualified human resources for research in the fields of Life 
Sciences, Environment and Earth "(April 2014 - December 2015)  
  
 
  National and international grants collaborator:       
1. „Ramses: Reinforcement of the Adult Stem cell research area through Mobility and 
Scientific networking between Egypt, Romania and a German Consortium for 
Strengthening the international scientific competence". Grant agreement no. 245691 
(November 2011 - August 2013); 
 
2. „Investigation of molecular mechanisms of integration and vasculogenesis of umbilical 
cord blood stem cells; implications for cardiovascular regeneration”, acronym" RE-
CORD ", PNCDI-II type TE (November 2011 - June 2013); 
 
3. „Effects of sex steroid son adult stem / progenitor cell mediated cardiovascular 
regeneration”, Romanian- Swiss Research Program (January 2013 - June 2016) 
 
 
4. „Improving institutional competitiveness in the field of type 1 diabetes by developing an 
innovative concept of mesenchymal stromal cell immunotherapy – DIABETER” (April 
2018 - present). 
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